Director/PDMR Shareholding

RNS Number : 8723I

Reckitt Benckiser Group PLC

22 June 2017

 

22 June 2017

RECKITT BENCKISER GROUP PLC

("RB" or the "Company")

 DIRECTOR/PDMR SHAREHOLDING

Notification of transactions of Directors/Persons Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

On 20 June 2017, Rob de Groot, Area Executive Vice President ENA, a PDMR, exercised 48,063 share options granted on 3 December 2012 at an option price of £38.06 per share. 32,113 of the resulting shares were disposed of at £79.9084250 per share to meet his resultant liabilities and the balance of 15,950 shares were retained.

Following these transactions, Mr de Groot's shareholding has increased to 330,005 Shares, representing 0.0469% of the Company's issued share capital. Treasury shares have not been taken into account when calculating this percentage.

The following notification is made in accordance with the requirements of the EU Market Abuse Regulation.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Rob de Groot
2	Reason for the notification
a)	Position/status	Area EVP, ENA
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Reckitt Benckiser Group plc
b)	LEI	5493003JFSMOJG48V108
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 10p each in Reckitt Benckiser Group plc ("Shares") GB00B24CGK77
b)	Nature of the transaction	Exercise of share options under the Reckitt Benckiser Group 2007 Long-Term Incentive Plan (the "2007 LTIP").  Sale of sufficient Shares to meet Mr de Groot's resultant liabilities and retention of balance. 1.   Acquisition of Shares pursuant to exercise of options under the 2007 LTIP. 2.   Disposal of Shares following share option exercise.
c)	Price(s) and volume(s)	Price(s) Volume(s) 1 GBP 38.06 48,063 2 GBP 79.9084250 32,113
d)	Aggregated information -       Aggregated volume -       Price	- -
e)	Date of the transaction	2017-06-20
f)	Place of the transaction	London Stock Exchange, Main Market - XLON

For further Information:
Christine Logan

Deputy Company Secretary
Tel [phone]

About RB:

RB* is the global leading consumer health and hygiene company. Driven by a purpose of providing innovative solutions for healthier lives and happier homes, RB has operations in over 60 countries.  From the foundations of wellness and infant nutrition, to the fundamentals of a hygienic home, its global brands help people live healthier, happier lives.

RB has world leading Powerbrands which include household names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, French's, Calgon, Woolite and Air Wick.

RB's unique culture is at the heart of its success.  Its drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 employees worldwide. RB is proud to lead the Save a Child a Minute campaign, which aims to eliminate child deaths from diarrhoea, one of the world's largest killers of children under five.

For more information visit www.rb.com 

*RB is the trading name of the Reckitt Benckiser group of companies

 

END

 

 

DSHGCGDLRGDBGRD